Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05458024 · ClinicalTrials.gov registry record · Phase 2
Vitamin D to ENhance TraUma REcovery
A Phase 2 study of Musculoskeletal Pain, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- Phase 2
- Development phase
- 71
- Enrollment target
- 4
- Study locations
NCT05458024 is a Phase 2 study of Musculoskeletal Pain that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 71 participants, below the 154-participant average among 37 other Musculoskeletal Pain trials with a reported enrollment target (54% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT05458024, a Phase 2 study of Musculoskeletal Pain, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 71 participants
- Enrollment target
- 4
- Study locations
Study Summary
The main objective of this study is to determine whether the administration of a single dose of Vitamin D in the Emergency Department following a motor vehicle collision can improve musculoskeletal pain severity as well as reduce musculoskeletal pain outcome disparity between Blacks and White following a motor vehicle collision. This randomized controlled trial is a pilot study to determine feasibility and potential efficacy (response to study drug, ability to reduce racial disparity in pain outcomes). This data can be used to adequately power a larger randomized controlled trial to fully assess efficacy.
Conditions Studied
Interventions
- DRUG Vitamin D 2
- DRUG Vitamin D2 Placebo
Study Locations (4)
Massachusetts
- University of Massachusetts Medical School - Worcester
Missouri
- Washington University School of Medicine - St Louis
New Jersey
- Cooper University Hospital - Camden
Rhode Island
- Rhode Island Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2023-01-24 |
| Est. Completion | 2024-05-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05458024
The ClinicalTrials.gov registry entry for NCT05458024 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 154-participant average among 37 other Musculoskeletal Pain trials with a reported enrollment target (54% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Musculoskeletal Pain appearing as the primary indexed condition, and to 2 interventions - of which Vitamin D 2 is the first listed.
NCT05458024 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Massachusetts, Missouri, New Jersey.
Frequently Asked Questions
What is clinical trial NCT05458024 about?
NCT05458024 is a clinical study titled "Vitamin D to ENhance TraUma REcovery". The main objective of this study is to determine whether the administration of a single dose of Vitamin D in the Emergency Department following a motor vehicle collision can improve musculoskeletal pain severity as well as reduce musculoskeletal pain outcome disparity between Blacks and White follow...
What is the current status of trial NCT05458024?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 71 participants. The study started on 2023-01-24. Estimated completion is 2024-05-01.
What conditions does trial NCT05458024 study?
This clinical trial studies the following conditions: Musculoskeletal Pain.
What interventions are being tested in trial NCT05458024?
The interventions under investigation include: Vitamin D 2 (DRUG), Vitamin D2 Placebo (DRUG).
Who is sponsoring clinical trial NCT05458024?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05458024 being conducted?
This trial has 4 study locations across Massachusetts, Missouri, New Jersey, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Musculoskeletal Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Altering The Transition From Acute to Chronic Pain (ATTAC-Pain)
COMPLETED · Phase 2
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Virtual Reality (VR) Self-Hypnosis Software
RECRUITING · NA
-
The PROACTIVE Study for Black Elders
RECRUITING · NA
-
Overlapping Pain Trajectory Study
RECRUITING
-
Neural Mechanisms of Light Driven Analgesia
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.